Citadel Advisors’s Tiziana Life Sciences TLSA Stock Holding History

Citadel Advisors’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$103K	Buy	80,222 +45,128	+129%	+$58.7K	﹤0.01%	12685
2026 Q1	$41.1K	Buy	+35,094	New	+$49.7K	﹤0.01%	12479
2025 Q3	–	Sell	-198,990	Closed	-$314K	–	14118
2025 Q2	$314K	Buy	+198,990	New	+$266K	﹤0.01%	9706
2024 Q4	–	Sell	-104,291	Closed	-$100K	–	15395
2024 Q3	$100K	Buy	+104,291	New	+$105K	﹤0.01%	11115
2022 Q3	–	Sell	-49,535	Closed	-$37K	–	13609
2022 Q2	$37K	Buy	49,535 +35,562	+255%	+$30.6K	﹤0.01%	12114
2022 Q1	$15K	Buy	+13,973	New	+$12.4K	﹤0.01%	13316
2021 Q2	–	Sell	-34,687	Closed	-$96K	–	14436
2021 Q1	$96K	Buy	+34,687	New	+$115K	﹤0.01%	12505
2020 Q4	–	Sell	-36,924	Closed	-$117K	–	11522
2020 Q3	$124K	Buy	+36,924	New	+$144K	﹤0.01%	9141
2020 Q1	–	Sell	-26,140	Closed	-$28K	–	10179
2019 Q4	$28K	Buy	+26,140	New	+$28.8K	﹤0.01%	8885
2019 Q2	–	Sell	-65,924	Closed	-$80K	–	9855
2019 Q1	$80K	Buy	+65,924	New	+$81.5K	﹤0.01%	8639

Other funds holding TLSA

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

MAWAG

Mid-American Wealth Advisory Group Kansas City, Missouri $277M AUM 6.22% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors's TLSA Position: Q2 2026 in Review

Citadel Advisors increased its Tiziana Life Sciences (TLSA) stake by 129% in Q2 2026, buying an estimated $58.7K and bringing the position to 80,222 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #12685.

Citadel Advisors first reported a position in TLSA in Q1 2019 and has held it in 10 quarters since. The position peaked at $314K in Q2 2025. 30 funds tracked by Wall St. Rank hold TLSA as of Q2 2026.

Citadel Advisors held 80,222 shares of Tiziana Life Sciences worth $103K as of Q2 2026.
Citadel Advisors bought 45,128 Tiziana Life Sciences shares in Q2 2026, an estimated $58.7K.
Tiziana Life Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12685 holding.
Citadel Advisors first reported a position in Tiziana Life Sciences in Q1 2019 and has held it in 10 quarters since.
Citadel Advisors's Tiziana Life Sciences position peaked at $314K in Q2 2025.
30 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.